Journal: Naunyn-Schmiedeberg's Archives of Pharmacology
Article Title: Anti-miRNA- 155 - 5p enhances the cytotoxic efficacy of temozolomide in brain cancer stem cells
doi: 10.1007/s00210-025-04135-6
Figure Lengend Snippet: Expression levels of miR- 155 - 5p. a ) Expression levels in glioblastoma and healthy brain tissues (To compare gene expression levels across different samples regardless of sequencing depth, Reads Per Million (RPM) is calculated by dividing the raw read count of a given transcript by the total number of mapped reads in the sample and multiplying by 10 6 .); b ) Expression levels in BCSCs compared to BSCs (RPM: Reads per million); c) Expression levels in anti-miR- 155 - 5p treated BCSCs and BSCs compared to untreated control cells Statistical significance was evaluated by Student’s t-test ( p < 0.05: *, p < 0.01: **, p < 0.001: ***, p < 0.0001: ****)
Article Snippet: BCSCs were obtained from Celprogen (Catalog No: 36110–37), and BSCs were sourced from the same provider (Catalog No: 36109–36, USA).
Techniques: Expressing, Gene Expression, Sequencing, Control